Report Details:
15 Companies Covered
163 Pages
Cardiac Implants Market Highlights
The Cardiac Implants Market Size was estimated at 46.43 USD Billion in 2024. The market is projected to grow from 50.0 in 2025 to 93.79 by 2035, exhibiting a compound annual growth rate (CAGR) of 6.56% during the forecast period 2025 - 2035.
Cardiac implants are used to control irregular heartbeats in people with heart disorders such as myocardial ischemia, arrhythmias, and acute myocardial infarction, among others. The increasing prevalence of cardiac diseases and the growing population of older adults across the globe is expected to propel the growth of the market. On the other hand, the high cost associated with cardiac implants and risk of injections due to these implants may restrain the market growth over the forecast period.
Segment analysis
The global cardiac implants market has been segmented into cardiac rhythm management devices, coronary stents, prosthetic heart valve devices, ventricular assist devices, implantable loop recorder/implantable cardiac monitor, and others.
By indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others. On the basis of end-user, the market has been segmented into hospitals, cardiac care centers, ambulatory centers & home care, academic institutes, and others.
Regional Analysis
Geographically, the Americas is expected to dominate the global cardiac implants market. In this region, the rising prevalence of cardiac diseases and high adoption rates of cardiac implantable electronic devices has led to the growth of the market.
In Europe, the cardiac implants market is anticipated to grow owing to the factors such as rising funding from the government for the healthcare sector and growing initiatives for heart patients by insurance companies in the region. Additionally, the rising prevalence of several heart diseases in the region has led to the increase in adoption of cardiac implants.
The Asia-Pacific region is expected to be the fastest growing market for cardiac implants. Factors such as the growing geriatric population, changing lifestyle, and the rising trend of medical tourism in the Asia-Pacific region are expected to drive the market. Furthermore, the Middle East and Africa accounts for the lowest share of the global market due to the presence of poor and slow developing countries, majorly, in the African region.
Market Research Future (MRFR) recognizes the following companies as the key players in the global cardiac implants market that includes Abbott (US), Amg International (Germany), Edwards Lifesciences Corporation (US), B. Braun Melsungen AG (Germany), Biotronik (US), Boston Scientific Corporation (US), LivaNova PLC (UK), Medtronic Plc (US), SynCardia Systems, Inc. (Arizona), and Terumo Corporation (Japan).
Key Findings of the Study:
- North America remains the largest market for cardiac implants, driven by advanced healthcare infrastructure and high patient awareness.
- The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and a burgeoning population.
- Coronary artery disease continues to dominate the market, while the arrhythmia segment is experiencing rapid growth due to increasing diagnosis rates.
- Technological advancements and the growing prevalence of cardiovascular diseases are key drivers propelling market expansion.
